Myron John Tong MD PhD
Transplantation
Professor, Digestive Diseases/Gastroenterology; Physician, Hepatology, UCLA School of Medicine
Join to View Full Profile
625 S Fair Oaks AvePasadena, CA 91105
Phone+1 626-975-9788
Fax+1 626-397-5836
Dr. Tong is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1971 - 1974- University of Southern California/Los Angeles General Medical Center (USC/LA General)Internship, Internal Medicine, 1966 - 1967
University of California San Francisco School of MedicineClass of 1966
Certifications & Licensure
CA State Medical License 1967 - 2025
American Board of Internal Medicine Internal Medicine
Clinical Trials
- A Phase II Study to Determine the Safety and Efficacy of Interferon-gamma in Patients With Chronic Hepatitis B Start of enrollment: 2008 Sep 01
- Placebo Controlled Study Using Lovaza as Treatment for Non-Alcoholic Fatty Liver Disease Start of enrollment: 2009 Sep 01
- Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection Start of enrollment: 2014 Dec 09
Publications & Presentations
PubMed
- Exposure to Agent Orange and Hepatocellular Carcinoma Among US Military Personnel.Jihane N Benhammou, Mei Leng, Shailja C Shah, George Cholankeril, Tien S Dong
JAMA Network Open. 2023-12-01 - 7 citationsEfficacy and Safety of a Botanical Formula Fuzheng Huayu for Hepatic Fibrosis in Patients with CHC: Results of a Phase 2 Clinical Trial.Tarek Hassanein, Dean Tai, Chenghai Liu, Terry D Box, Myron J Tong
Evidence-Based Complementary and Alternative Medicine. 2022-01-01 - 9 citationsNonalcoholic fatty liver disease-related hepatocellular carcinoma growth rates and their clinical outcomesJihane N. Benhammou, Jonathan H. Lin, Elizabeth S. Aby, Daniela Markovic, Steven S. Raman
Hepatoma Research. 2021-11-05
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
